7,771
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Anticarcinogenecity of microbiota and probiotics in breast cancer

, , , , &
Pages 655-666 | Received 29 Aug 2017, Accepted 03 Mar 2018, Published online: 04 May 2018

References

  • Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics. CA: A Cancer Journal for Clinicians 2016, 66(1), 7–30.
  • Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer Statistics. CA: A Cancer Journal for Clinicians 2010, 60(5), 277–300.
  • Anderson, K. N.; Schwab, R. B.; Martinez, M. E. Reproductive Risk Factors and Breast Cancer Subtypes: A Review of the Literature. Breast Cancer Research Treatment 2014, 144(1), 1–10.
  • Barnard, M. E.; Boeke, C. E.; Tamimi, R. M. Established Breast Cancer Risk Factors and Risk of Intrinsic Tumor Subtypes. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 2015, 1856(1), 73–85.
  • Malik, S. S.; Masood, N.; Yasmin, A. Prostate Cancer and Glutathione S-Transferase Deletions. EXCLI J 2015, 14, 1049.
  • Xing, P.; Li, J.; Jin, F. A Case–Control Study of Reproductive Factors Associated with Subtypes of Breast Cancer in Northeast China. Medical Oncology 2010, 27(3), 926–931.
  • Tamimi, R. M.; Colditz, G. A.; Hazra, A.; Baer, H. J.; Hankinson, S. E.; Rosner, B.; Marotti, J.; Connolly, J. L.; Schnitt, S. J.; Collins, L. C. Traditional Breast Cancer Risk Factors in Relation to Molecular Subtypes of Breast Cancer. Breast Cancer Research Treatment 2012, 131(1), 159–167.
  • Saxena, T.; Lee, E.; Henderson, K. D.; Clarke, C. A.; West, D.; Marshall, S. F.; Deapen, D.; Bernstein, L.; Ursin, G. Menopausal Hormone Therapy and Subsequent Risk of Specific Invasive Breast Cancer Subtypes in the California Teachers Study. Cancer Epidemiology Biomarkers and Prevention 2010, 19(9), 1055–9965.
  • Gaudet, M. M.; Press, M. F.; Haile, R. W.; Lynch, C. F.; Glaser, S. L.; Schildkraut, J.; Gammon, M. D.; Thompson, W. D.; Bernstein, J. L. Risk Factors by Molecular Subtypes of Breast Cancer across a Population-Based Study of Women 56 Year or Younger. Breast Cancer Research and Treatment 2011, 130(2), 587–597.
  • Razzaghi, H.; Troester, M. A.; Gierach, G. L.; Olshan, A. F.; Yankaskas, B. C.; Millikan, R. C. Association between Mammographic Density and Basal-Like and Luminal A Breast Cancer Subtypes. Breast Cancer Research 2013, 15(5), 76.
  • Sieri, S.; Pala, V.; Brighenti, F.; Agnoli, C.; Grioni, S.; Berrino, F.; Scazzina, F.; Palli, D.; Masala, G.; Vineis, P.; et al. High Glycemic Diet and Breast Cancer Occurrence in the Italian EPIC Cohort. Nutrition, Metabolism and Cardiovascular Diseases 2013, 23(7), 628–634.
  • Khan, A. A.; Khurshid, M.; Khan, S.; Alshamsan, A. Gut Microbiota and Probiotics: Current Status and Their Role in Cancer Therapeutics. Drug Development Research 2013, 74, 365–375.
  • Maldonado Galdeano, C.; de Moreno de LeBlanc, A.; Vinderola, G.; Bibas Bonet, M. E.; Perdigo, G. Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria. Clinical and Vaccine Immunology 2007, 14(5), 485–492. DOI:10.1128/CVI.00406-06.
  • Ranadheera, R. D. C. S.; Baines, S. K.; Adams, M. C. Importance of Food in Probiotic Efficacy. Food Res., Intl 2010, 43, 1–7.
  • Fariq, A.; Production, S. A. Biomedical Applications of Probiotic Biosurfactants. Current Microbiology 2016, 72, 489–495.
  • Jost, T.; Lacroix, C.; Braegger, C. P.; Rochat, F.; Chassard, C. Vertical Mother–Neonate Transfer of Maternal Gut Bacteria via Breastfeeding. Environmental Microbiology 2014, 16(9). 2891–2904. DOI:10.1111/1462-2920.12238.
  • Gibson, G. R.; Fuller, R. Aspects of In-Vitro and In-Vivo Research Approaches Directed Towards Identifying Probiotics and Probiotics for Human Use. Journal of Nutrition 2000, 130, 391–395.
  • Kumar, M.; Kumar, A.; Nagpal, R.; Mohania, D.; Behare, P.; Verma, V.; Kumar, P.; Poddari, D.; Aggarwal, P. K.; Henry, C. J. K.; et al. Attributes of Probiotics: An Update. IInternational Journal of Food Sciences and Nutrition 2010, 61(5), 473–496.
  • Chong, E. S. L.; Potential, A. Role of Probiotics in Colorectal Cancer Prevention: Review of Possible Mechanisms of Action. World Journal of Microbiology and Biotechnology. 2013. DOI:10.1007/s11274-013-1499-6.
  • Argyri, A. A.; Zoumpopoulou, G.; Karatzas, K. G.; Tsakalidou, E.; Nychas, G. E.; Panagou, E. Z.; Tassou, C. C. Selection of Potential Probiotic Lactic Acid Bacteria from Fermented Olives by In-Vitro Tests. Food Microbiology 2013, 33, 282–291.
  • Verna, E.; Lucak, S. Use of Probiotics in Gastrointestinal Disorders: What to Recommend?. Therapeutic Advances in Gastroenterology 2010, 3, 307–319.
  • Efficacy, K. T. Safety of the Probiotic Saccharomyces Boulardii for the Prevention and Therapy of Gastrointestinal Disorders. Therapeutic Advances in Gastroenterology 2012, 5(2), 111–125.
  • Morrow, L. E.; Gogineni, V.; Malesker, M. A. Probiotics in the Intensive Care Unit. Nutrition in Clinical Practice 2012, 27(2), 235–241.
  • Hoque, M. Z.; Akter, F.; Hossain, K. M.; Rahman, M. S. M.; Billah, M. M.; Islam, K. M. D.; Isolation, I. Analysis of Probiotic Properties of Lactobacillus Spp. From Selective Regional Yoghurts. World Journal of  Dairy & Food Sciences 2010, 5(1), 39–46.
  • Khan, A. A.; Shrivastava, A.; Khurshid, M. Normal to Cancer Microbiome Transformation and Its Implication in Cancer Diagnosis. Biochimica et Biophysica Acta (BBA) 2012, 1826, 331–337.
  • Lankaputhra, W. E. V.; Shah, N. P. Antimutagenic Properties of Probiotic Bacteria and of Organic Acids. Mutation Research 1998, 397, 169–182.
  • Wollowski, I.; Rechkemmer, G.; Pool-Zobel, B. L. Protective Role of Probiotics and Prebiotics in Colon Cancer. The American Journal of Clinical Nutrition 2001, 73, 451–455.
  • LeBlanc, J. G.; Matar, C.; Valdez, J. C.; LeBlanc, J.; Perdigon, G. Immunomodulating Effects of Peptidic Fractions Issued from Milk Fermented with Lactobacillus Helveticus. Journal of Dairy Science 2002, 85, 2733–2742.
  • Le Leu, R. K.; Brown, I. L.; Hu, Y.; Bird, A. R.; Jackson, M.; Esterman, A.; Young, G. P.; Synbiotic, A. Combination of Resistant Starch and Bifidobacterium Lactis Facilitates Apoptotic Deletion of Carcinogen-Damaged Cells in Rat Colon. Journal of Nutrition 2005, 135, 996–1001.
  • Hlivak, P.; Odraska, J.; Ferencik, M.; Ebringer, L.; Jahnova, E.; One-Year, M. Z. Application of Probiotic Strain Enterococcus Faecium M-74 Decreases Serum Cholesterol Levels. Bratislavsk´e l´ek´a¡rske listy 2005, 106, 67–72.
  • Hsieh, M. L.; Chou, C. C. Mutagenicity and Antimutagenic Effect of Soymilk Fermented with Lactic Acid Bacteria and Bifidobacteria. International Journal of Food Microbiology 2006, 111, 43–47.
  • Maldonado Galdeano, C.; Perdigion, G. The Probiotic Bacterium Lactobacillus Casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity. Clinical and Vaccine Immunology 2006, 13, 219–226.
  • Shah, N. P.; Functional Cultures and Health Benefits. In: International- Dairy-Federation Symposium on Rheology and Structure of Fermented Milk, Elsevier Science Ltd, Oxford, England/Sirmione, Italy, 2006; 35–36.
  • Shah, N. P. Functional Cultures and Health Benefits. International Dairy Journal 2007, 17, 1262–1277.
  • Vasiljevic, T.; Shah, N. P. Fermented Milk-Health Benefits beyond Probiotic Effect. In Handbook of Food Products Manufacturing; Hui, Y. H., Ed..; John Wiley and Sons, Inc: Hoboken, NJ, 2007.
  • Amit-Romach, E.; Uni, Z.; Reifen, R. Therapeutic Potential of Two Probiotics in Inflammatory Bowel Disease as Observed in the Trinitrobenzene Sulfonic Acid Model of Colitis. Diseases of the Colon & Rectum 2008, 51, 1828–1836.
  • Paineau, D.; Carcano, D.; Leyer, G.; Darquy, S.; Alyanakian, M. A.; Simoneau, G.; Bergmann, J. F.; Brassart, D.; Bornet, F.; Ouwehand, A. C. Effects of Seven Potential Probiotic Strains on Specific Immune Responses in Healthy Adults: A Double-Blind, Randomized, Controlled Trial. FEMS Immunology and Medical Microbiology 2008, 53, 107–113.
  • Prescott, S. L.; Wickens, K.; Westcott, L.; Jung, W.; Currie, H.; Black, P. N.; Stanley, T. V.; Mitchell, E. A.; Fitzharris, P.; Siebers, R.; et al. Supplementation with Lactobacillus Rhamnosus or Bifidobacterium Lactis Probiotics in Pregnancy Increases Cord Blood Interferon-γ and Breast Milk Transforming Growth Factor-β and Immunoglobin A Detection. Clinical & Experimental Allergy 2008, 38, 1606–1614.
  • Pronio, A.; Montesani, C.; Butteroni, C.; Vecchione, S.; Mumolo, G.; Vestri, A.; Vitolo, D.; Boirivant, M. Probiotic Administration in Patients with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis Is Associated with Expansion of Mucosal Regulatory Cells. Inflammatory Bowel Diseases 2008, 14, 662–668.
  • Probiotics, R. G. Prebiotics—Progress and Challenges. International Dairy Journal 2008, 18, 969–975.
  • Ryan, K. A.; O’Hara, A. M.; Van Pijkeren, J. P.; Douillard, F. P.; O’Toole, P. W. Lactobacillus Salivarius Modulates Cytokine Induction and Virulence Factor Gene Expression in Helicobacter Pylori. Journal of Medical Microbiology 2009, 58, 996–1005.
  • Van Hai, N.; Buller, N.; Fotedar, R. The Use of Customised Probiotics in the Cultivation of Western King Prawns (Penaeus Latisulcatus Kishinouye, 1896). Fish & Shellfish Immunology 2009, 27, 100–104.
  • Aragon, F.; Perdigon, G.; De LeBlanc, A. D. Modification in the Diet Can Induce Beneficial Effects against Breast Cancer. World Journal of Clinical Oncology 2014, 5(3), 455.
  • Chajes, V.; Romieu, I. Nutrition and Breast Cancer. Maturitas 2014, 77, 7–11.
  • Thomson, C. A. Diet and Breast Cancer: Understanding Risks and Benefits. Nutrition in Clinical Practice 2012, 27(5), 636–650.
  • Rodriguez, S. F.; Aguilar, M. A.; Manuel-y-Keenoy, B. Influence of Body Weight on the Prognosis of Breast Cancer Survivors; Nutritional Approach after Diagnosis. Nutricion Hospitalaria 2013, 28(6), 1829–1841.
  • Chaudhry, Z. W.; Brown, R. V.; Fawole, O. A.; Wilson, R.; Gudzune, K. A.; Maruthur, N. M.; Segal, J.; Hutfless, S. M. Comparative Effectiveness of Strategies to Prevent Weight Gain among Women with and at Risk for Breast Cancer: A Systematic Review. SpringerPlus 2013, 2(1), 277.
  • Patterson, R. E.; Flatt, S. W.; Newman, V. A.; Natarajan, L.; Rock, C. L.; Thomson, C. A.; Caan, B. J.; Parker, B. A.; Pierce, J. P. Marine Fatty Acid Intake Is Associated with Breast Cancer Prognosis. Journal of Nutrition 2011, 141(2), 201–206.
  • De Lorgeril, M.; Salen, P. New Insights into the Health Effects of Dietary Saturated and Omega-6 and Omega-3 Polyunsaturated Fatty Acids. BMC Medicine 2012, 10(1), 50.
  • Cho, K.; Mabasa, L.; Fowler, A. W.; Walsh, D. M.; Park, C. S. Canola Oil Inhibits Breast Cancer Cell Growth in Cultures and In-Vivo and Acts Synergistically with Chemotherapeutic Drugs. Lipids 2010, 45(9), 777–784.
  • Mabasa, L.; Cho, K.; Walters, M. W.; Bae, S.; Park, C. S. Maternal Dietary Canola Oil Suppresses Growth of Mammary Carcinogenesis in Female Rat Offspring. Nutrition and Cancer 2013, 65(5), 695–701.
  • Aune, D.; Chan, D. S.; Vieira, A. R.; Rosenblatt, D. N.; Vieira, R.; Greenwood, D. C.; Fruits, N. T. Vegetables and Breast Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies. Breast Cancer Research and Treatment 2012, 134(2), 479–493.
  • Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer–collaborative reanalysis of individual data from. 53 Epidemiological Studies, Including 58 515 Women with Breast Cancer and 95 067 Women without the Disease. British Journal of Cancer 2002, 87(11), 1234.
  • Chi, F.; Wu, R.; Zeng, Y. C.; Xing, R.; Liu, Y.; Xu, Z. G. Post-Diagnosis Soy Food Intake and Breast Cancer Survival: A Meta-Analysis of Cohort Studies. Asian Pacific Journal of Cancer Prevention 2013, 14(4), 2407–2412.
  • Nagata, C.; Mizoue, T.; Tanaka, K.; Tsuji, I.; Tamakoshi, A.; Matsuo, K.; Wakai, K.; Inoue, M.; Tsugane, S.; Sasazuki, S. Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Soy Intake and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence among the Japanese Population. Japanese Journal of Clinical Oncology 2014, 44(3), 282–295.
  • Setchell, K. D. Soy Isoflavones—Benefits and Risks from Nature’s Selective Estrogen Receptor Modulators (Serms). Journal of the American College of Nutrition 2001, 20(5), 354–362.
  • Montales, M. T.; Rahal, O. M.; Kang, J.; Rogers, T. J.; Prior, R. L.; Wu, X.; Simmen, R. C. Repression of Mammosphere Formation of Human Breast Cancer Cells by Soy Isoflavone Genistein and Blueberry Polyphenolic Acids Suggests Diet-Mediated Targeting of Cancer Stem-Like/Progenitor Cells. Carcinogenesis 2012, 33(3), 652–660.
  • Montales, M. T.; Rahal, O. M.; Nakatani, H.; Matsuda, T.; Simmen, R. C. Repression of Mammary Adipogenesis by Genistein Limits Mammosphere Formation of Human MCF-7 Cells. Journal of Endocrinology 2013, 218(1), 135–149.
  • Lajous, M.; Lazcano-Ponce, E.; Hernandez-Avila, M.; Willett, W.; Folate, R. I. Vitamin B6, and Vitamin B12 Intake and the Risk of Breast Cancer among Mexican Women. Cancer Epidemiology, Biomarkers & Prevention 2006, 15(3), 443–448.
  • Shrubsole, M. J.; Gao, Y. T.; Cai, Q.; Shu, X. O.; Dai, Q.; Hébert, J. R.; Jin, F.; Zheng, W. MTHFR Polymorphisms, Dietary Folate Intake, and Breast Cancer Risk. Cancer Epidemiology, Biomarkers & Prevention 2004, 13(2), 190–196.
  • Gao, C. M.; Tang, J. H.; Cao, H. X.; Ding, J. H.; Wu, J. Z.; Wang, J.; Liu, Y. T.; Li, S. P.; Su, P.; Matsuo, K.; et al. Dietary Folate Intake and Breast Cancer Risk in Chinese Women. Journal of Human Genetics 2009, 54(7), 1–8.
  • Alshatwi, A. A. Breast Cancer Risk, Dietary Intake and Methylenetetrahydrofolate Reductase (MTHFR) Single Nucleotide Polymorphisms. Food and Chemical Toxicology 2010, 48(7), 1881–1885.
  • Castillo, L. C.; Tur, J. A.; Folate, U. R. Breast Cancer Risk: A Systematic Review. Revista medica de Chile 2012, 140(2), 251–260.
  • Yan, L.; DeMars, L. C. Dietary Supplementation with Methylseleninic Acid, but Not Selenomethionine, Reduces Spontaneous Metastasis of Lewis Lung Carcinoma in Mice. International Journal of Cancer 2012, 131(6), 1260–1266.
  • Bassett, J. K.; Baglietto, L.; Hodge, A. M.; Severi, G.; Hopper, J. L.; English, D. R.; Giles, G. G. Dietary Intake of B Vitamins and Methionine and Breast Cancer Risk. Cancer Causes Control 2013, 24(8), 1555–1563.
  • Ha, A. W.; Hong, K. H.; Kim, H. S.; Kim, W. K. Inorganic Sulfur Reduces Cell Proliferation by Inhibiting of ErbB2 and ErbB3 Protein and mRNA Expression in MDA-MB-231 Human Breast Cancer Cells. Nutrition Research and Practice 2013, 7(2), 89–95.
  • Reid, G.; Sanders, M. E.; Gaskins, H. R.; Gibson, G. R.; Mercenier, A.; Rastall, R. M.; Roberfroid, M.; Rowland, I.; Cherbut, C.; Klaenhammer, T. R. New Scientific Paradigms for Probiotics and Prebiotics. Journal of Clinical Gastroenterology 2003, 37, 105–118.
  • Kinjo, Y.; Wu, D.; Kim, G.; Guo-Wen, X. Recognition of Bacterial Glycosphingolipids by Natural Killer T Cells. Nature 2005, 434(7032), 520.
  • Terabe, M.; Berzofsky, J. A. N. K. T. Cells in Immunoregulation of Tumor Immunity: A New Immunoregulatory Axis. Trends in Immunology 2007, 28(11), 491–496.
  • Hix, L. M.; Shi, Y. H.; Brutkiewicz, R. R.; Stein, P. L.; Wang, C. R.; Zhang, M. CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis. PLOS One 2011, 6(6), 202–207.
  • Modarressi, R. E.; Daneshvar, M.; Beigom, M.; Mobasheri, E. M. Lactobacillus Acidophilus and Lactobacillus Crispatus Culture Supernatants Downregulate Expression of Cancer-Testis Genes in the MDA-MB-231 Cell Line. Asian Pacific Journal of Cancer Prevention 2014, 15(10), 4255–4259.
  • Lee, J. H.; Nam, S. H.; Seo, W. T.; Yun, H. D.; Hong, S. Y.; Kim, M. K.; Cho, K. M. The Production of Surfactin during the Fermentation of Cheonggukjang by Potential Probiotic Bacillus Subtilis CSY191 and the Resultant Growth Suppression of MCF-7 Human Breast Cancer Cells. Food Chemistry 2012, 131, 1347–1354.
  • Soltan Dallal, M. M.; Yazdi, M. H.; Holakuyee, M.; Hassan, Z. M.; Abolhassani, M.; Mahdavi, M. Lactobacillus Casei Ssp.Casei Induced Th1 Cytokine Profile and Natural Killer Cells Activity in Invasive Ductal Carcinoma Bearing Mice. Iranian Journal of Allergy, Asthma and Immunology 2012, 11, 183–189.
  • Takeda, K.; Okumura, K. Effects of a Fermented Milk Drink Containing Lactobacillus Casei Strain Shirota on the Human NK Cell Activity. Journal of Nutrition 2007, 137(3), 791–793.
  • Morimoto, K.; Takeshita, T.; Nanno, M.; Tokudome, S.; Nakayama, K. Modulation of Natural Killer Cell Activity by Supplementation of Fermented Milk Containing Lactobacillus Casei in Habitual Smokers. Preventive Medicine 2005, 40(5), 589–594.
  • Ho, Y. H.; Lu, Y. C.; Chang, H. C.; Lee, S. Y.; Tsai, M. F.; Huang, Y. T.; Hsu, T. Y. Daily Intake of Probiotics with High IFN-γ/IL-10; ratio increases the cytotoxicity of human natural killer cells: A personalized probiotic approach. Journal of Immunology Research, 2014, 1–7. https://www.hindawi.com/journals/jir/2014/721505/
  • de Moreno de LeBlanc, A.; Matar, C.; LeBlanc, N.; Perdigon, G. Effects of Milk Fermented by Lactobacillus Helveticus R389 on a Murine Breast Cancer Model. Breast Cancer Research 2005, 7, 477–486.
  • Yazdi, M. H.; Mahdavi, M.; Kheradmand, E.; Shahverdi, A. R. The Preventive Oral Supplementation of a Selenium Nanoparticle Enriched Probiotic Increases the Immune Response and Lifespan of 4T1 Breast Cancer Bearing Mice. Arzneimittel-Forschung 2012, 62, 525–531.
  • Yazdi, M. H.; Mahdavi, M.; Setayesh, N.; Esfandyar, M.; Shahverdi, A. R.; Nanoparticle-Enriched, S. Lactobacillus Brevis Causes More Efficient Immune Responses In-Vivo and Reduces the Liver Metastasis in Metastatic Form of Mouse Breast Cancer. DARU Journal of Pharmaceutical Sciences 2013, 21(1), 33.
  • Maroof, H.; Hassan, Z. M.; Mobarez, A. M.; Mohamadabadi, M. A. Lactobacillus Acidophilus Could Modulate the Immune Response against Breast Cancer in Murine Model. Journal of Clinical Immunology 2012, 32(6), 1353–1359.
  • Nami, Y.; Abdullah, N.; Haghshenas, B.; Radiah, D.; Rosli, R.; Khosroushahi, A. Y.; Potential, P. Biotherapeutic Effects of Newly Isolated Vaginal Lactobacillus Acidophilus 36YL Strain on Cancer Cells. Anaerobe 2014, 28, 29–36.
  • Synowiec, E.; Stefanska, J.; Morawiec, Z.; Blasiak, J.; Wozniak, K. Association between DNA Damage, DNA Repair Genes Variability and Clinical Characteristics in Breast Cancer Patients. Mutation Research 2008, 648, 65–72.
  • Davis, P. J.; Davis, F. B.; Mousa, S. A.; Luidens, M. K.; Lin, H. Y. Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications. Annual Review of Pharmacology and Toxicology 2011, 51, 99–115.
  • Walsh, M.; Gardiner, G.; Hart, O.; Lawlor, P.; Daly, M.; Lynch, B. Predominance of a Bacteriocin-Producing Lactobacillus Salivarius Component of a Five-Strain Probiotic in the Porcine Ileum and Effects on Host Immune Phenotype. FEMS Microbiology and Ecology 2008, 64(2), 317–327. DOI:10.1111/j.1574-6941.2008.00454.x.
  • Jara, L.; Dubois, K.; Gaete, D.; De Mayo, T.; Ratkevicius, N.; Bravo, T.; Margarit, S.; Blanco, R.; Gómez, F.; Waugh, E.; et al. Variants in DNA Double-Strand Break Repair Genes and Risk of Familial Breast Cancer in a South American Population. Breast Cancer Research and Treatment 2010, 122, 813–822.
  • Gonzalez-Angulo, A. M.; Timms, K. M.; Liu, S.; Chen, H.; Litton, J. K.; Potter, J.; Lanchbury, J. S.; Stemke-Hale, K.; Hennessy, B. T.; Arun, B. K.; et al. Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer. Clinical Cancer Research 2011, 17, 1082–1089.
  • Dolara, P.; Luceri, C.; De Filippo, C.; Femia, A. P.; Giovannelli, L.; Caderni, G.; Cresci, A. Red Wine Polyphenols Influence Carcinogenesis, Intestinal Microflora, Oxidative Damage and Gene Expression Profiles of Colonic Mucosa in F344 Rats. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2005, 591(1), 237–246.
  • Commane, D.; Hughes, R.; Shortt, C.; Rowland, I. The Potential Mechanisms Involved in the Anti-Carcinogenic Action of Probiotics. Mutation Research 2005, 591, 276–289.
  • Burns, A. J.; Rowland, I. R. Antigenotoxicity of Probiotics and Prebiotics on Faecal Water-Induced DNA Damage in Human Colon Adenocarcinoma Cells. Mutation Research 2004, 551, 233–243.
  • McMullen, M. H.; Hamilton-Reeves, J. M.; Bonorden, M. J.; Wangen, K. E.; Phipps, W. R.; Feirtag, J. M.; Kurzer, M. S. Consumption of Lactobacillus Acidophilus and Bifidobacterium Longum Does Not Alter Phytoestrogen Metabolism and Plasma Hormones in Men: A Pilot Study. Journal of Alternative and Complementary Medicine 2006, 12(9), 887–894.
  • Kaga, C.; Takagi, A.; Kano, M.; Kado, S.; Kato, I.; Sakai, M.; Miyazaki, K.; Nanno, M.; Ishikawa, F.; Ohashi, Y.; et al. Lactobacillus Casei Shirota Enhances the Preventive Efficacy of Soymilk in Chemically Induced Breast Cancer. Cancer Science 2013, 104(11), 1508–1514.
  • Toi, M.; Hirota, S.; Tomotaki, A.; Sato, N.; Hozumi, Y.; Anan, K.; Nagashima, T.; Tokuda, Y.; Masuda, N.; Ohsumi, S.; et al. Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-Control Study. Current Nutrition and Food Science 2013, 9(3), 194–200.
  • Liong, M. T. Probiotics: A Critical Review of Their Potential Role as Antihypertensives, Immune Modulators, Hypocholesterolemics, and Perimenopausal Treatments. Nutrition Reviews 2007, 65(7), 316–328.
  • Donkor, O. N.; Shah, N. P.; Apostolopoulos, V.; Vasiljevic, T. Development of Allergic Responses Related to Microorganisms Exposure in Early Life. International Dairy Journal 2010, 20, 373–385.
  • Kopp, M.; Hennemuth, I.; Heinzmann, A.; Randomized, U. R. Double-Blind, Placebo-Controlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation. Pediatrics 2008, 121(4), 850–856.
  • Ashraf, R.; Shah, N. P. Immune System Stimulation by Probiotic Microorganisms. Critical Reviews in Food Science and Nutrition 2014, 54(7), 938–956.
  • Galdeano, C.; de Moreno de LeBlanc, A.; Vinderola, G.; Bibas-Bonet, M. E.; Perdigón, G.; Proposal Model:, A. Mechanisms of Immunomodulation Induced by Probiotic Bacteria. Review. Clinical and Vaccine Immunology 2007, 14, 485–492.
  • Dogi, C. A.; Weill, F.; Perdigon, G. Immune Response of Nonpathogenic Gram (+) and Gram (−) Bacteria in Inductive Sites of the Intestinal Mucosa Study of the Pathway of Signaling Involved. Immunobiology 2010, 215, 60–69.
  • Choi, S. S.; Kim, Y.; Han, K. S.; You, S.; Oh, S.; Kim, S. H. Effects of Lactobacillus Strains on Cancer Cell Proliferation and Oxidative Stress In-Vitro. Letters in Applied Microbiology 2006, 42, 452–458.
  • Hassan, Z.; Mustafa, S.; Rahim, R. A.; Isa, N. M. Anti-Breast Cancer Effects of Live, Heat-Killed and Cytoplasmic Fractions of Enterococcus Faecalis and Staphylococcus Hominis Isolated from Human Breast Milk. In Vitro Cellular and Developmental Biology – Animal 2016, 52, 337–348.
  • Hirayama, K.; Rafter, J. The Role of Probiotic Bacteria in Cancer Prevention. Microbes and Infection 2000, 2(6), 681–686.
  • Kim, P. I.; Jung, M. Y.; Chang, Y. H.; Kim, S.; Kim, S. J.; Park, Y. H. Probiotic Properties of Lactobacillus and Bifidobacterium Strains Isolated from Porcine Gastrointestinal Tract. Applied Microbiology and Biotechnology 2007, 74(5), 1103–1111.
  • Tan, H. K.; Foo, H. L.; Loh, T. C.; Alitheen, N. B. M.; Rahim, R. A. Cytotoxic Effect of Proteinaceous Postbiotic Metabolites Produced by Lactobacillus Plantarum I-UL4 Cultivated in Different Media Composition on MCF-7 Breast Cancer Cell. Malaysian Journal of Microbiology 2015, 11(2), 207–214.
  • Saarela, M.; Mogensen, G.; Fonden, R.; Mättö, J.; Mattila-Sandholm, T. Probiotic Bacteria: Safety, Functional and Technological Properties. Journal of Biotechnology 2000, 84(3), 197–215.
  • Lim, B. K.; Mahendran, R.; Lee, Y. K.; Bay, B. H. Chemopreventive Effect of Lactobacillus Rhamnosus on Growth of a Subcutaneously Implanted Bladder Cancer Cell Line in the Mouse. Japanese Journal of Cancer Research 2002, 93, 36–41.
  • de Moreno de LeBlanc, A.; Matar, C.; Farnworth, E.; Perdigon, G. Study of Immune Cells Involved in the Antitumor Effect of Kefir in a Murine Breast Cancer Model. Journal of Dairy Science 2007, 90, 1920–1928.
  • Iyer, C.; Kosters, A.; Sethi, G.; Kunnumakkara, A. B.; Aggarwal, B. B.; Probiotic, V. J. Lactobacillus Reuteri Promotes TNF-induced Apoptosis in Human Myeloid Leukemia-Derived Cells by Modulation of NF-kB and MAPK Signaling. Cellular Microbiology 2008, 10(7), 1442–1452.
  • Burns, A. J. R.; Rowland, I. R. Anti-Carcinogenicity of Probiotics and Prebiotics. Intestinal Microbiology 2000, 1(1), 13–24.
  • Kassayova, M.; Bobrov, N.; Strojny, L.; Kiskova, T.; Mikes, J.; Demeckova, V. Preventive Effects of Probiotic Bacteria Lactobacillus Plantarum and Dietary Fiber in Chemically-Induced Mammary Carcinogenesis. Anticancer Research 2014, 34(9), 4969–4975.
  • De Preter, V.; Raemen, H.; Cloetens, L.; Houben, E.; Rutgeerts, P.; Verbeke, K. Effect of Dietary Intervention with Different Pre-and Probiotics on Intestinal Bacterial Enzyme Activities. European Journal of Clinical Nutrition 2008, 62(2), 225.
  • Oberreuther-Moschner, D. L.; Jahreis, G.; Rechkemmer, G.; Pool-Zobel, B. L. Dietary Intervention with the Probiotics Lactobacillus Acidophilus 145 and Bifidobacterium Longum 913 Modulates the Potential of Human Faecal Water to Induce Damage in HT29clone19A Cells. British Journal of Nutrition 2004, 91(6), 925–932.